CBR4 anticorps (N-Term)
Aperçu rapide pour CBR4 anticorps (N-Term) (ABIN926567)
Antigène
Voir toutes CBR4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- CBR4 antibody was raised in rabbit using the N terminal of CBR4 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CBR4 Blocking Peptide, (ABIN5612697), is also available for use as a blocking control in assays to test for specificity of this CBR4 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CBR4 (Carbonyl Reductase 4 (CBR4))
-
Autre désignation
- CBR4
-
Sujet
- The heteroteramer with HSD17B8 has NADH-dependent 3-ketoacyl-acyl carrier protein reductase activity. May play a role in biosynthesis of fatty acids in mitochondria. The homotetramer may act as NADPH-dependent quinone reductase. It has broad substrate specificity and reduces 9,10-phenanthrenequinone, 1,4-benzoquinone and various other o-quinones and p-quinones (in vitro). Synonyms: Polyclonal CBR4 antibody, Anti-CBR4 antibody, carbonyl reductase 4 antibody, FLJ14431 antibody, SDR45C1 antibody.
Antigène
-